Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Sarrió D[au]:

Search results

Items: 31

1.

Gasdermin B expression predicts poor clinical outcome in HER2-positive breast cancer.

Hergueta-Redondo M, Sarrio D, Molina-Crespo Á, Vicario R, Bernadó-Morales C, Martínez L, Rojo-Sebastián A, Serra-Musach J, Mota A, Martínez-Ramírez Á, Castilla MÁ, González-Martin A, Pernas S, Cano A, Cortes J, Nuciforo PG, Peg V, Palacios J, Pujana MÁ, Arribas J, Moreno-Bueno G.

Oncotarget. 2016 Aug 30;7(35):56295-56308. doi: 10.18632/oncotarget.10787.

2.

WIP and WICH/WIRE co-ordinately control invadopodium formation and maturation in human breast cancer cell invasion.

García E, Ragazzini C, Yu X, Cuesta-García E, Bernardino de la Serna J, Zech T, Sarrió D, Machesky LM, Antón IM.

Sci Rep. 2016 Mar 24;6:23590. doi: 10.1038/srep23590.

3.

Gasdermin-B promotes invasion and metastasis in breast cancer cells.

Hergueta-Redondo M, Sarrió D, Molina-Crespo Á, Megias D, Mota A, Rojo-Sebastian A, García-Sanz P, Morales S, Abril S, Cano A, Peinado H, Moreno-Bueno G.

PLoS One. 2014 Mar 27;9(3):e90099. doi: 10.1371/journal.pone.0090099. eCollection 2014.

4.

MicroRNA-200 family modulation in distinct breast cancer phenotypes.

Castilla MÁ, Díaz-Martín J, Sarrió D, Romero-Pérez L, López-García MÁ, Vieites B, Biscuola M, Ramiro-Fuentes S, Isacke CM, Palacios J.

PLoS One. 2012;7(10):e47709. doi: 10.1371/journal.pone.0047709. Epub 2012 Oct 24.

5.

Epithelial and mesenchymal subpopulations within normal basal breast cell lines exhibit distinct stem cell/progenitor properties.

Sarrio D, Franklin CK, Mackay A, Reis-Filho JS, Isacke CM.

Stem Cells. 2012 Feb;30(2):292-303. doi: 10.1002/stem.791.

6.

Endoglin expression in breast tumor cells suppresses invasion and metastasis and correlates with improved clinical outcome.

Henry LA, Johnson DA, Sarrió D, Lee S, Quinlan PR, Crook T, Thompson AM, Reis-Filho JS, Isacke CM.

Oncogene. 2011 Mar 3;30(9):1046-58. doi: 10.1038/onc.2010.488. Epub 2010 Nov 1.

PMID:
21042283
7.

Pathogenetic pathways in ovarian endometrioid adenocarcinoma: a molecular study of 29 cases.

Geyer JT, López-García MA, Sánchez-Estevez C, Sarrió D, Moreno-Bueno G, Franceschetti I, Palacios J, Oliva E.

Am J Surg Pathol. 2009 Aug;33(8):1157-63. doi: 10.1097/PAS.0b013e3181a902e1.

PMID:
19542870
8.

Functional characterization of E- and P-cadherin in invasive breast cancer cells.

Sarrió D, Palacios J, Hergueta-Redondo M, Gómez-López G, Cano A, Moreno-Bueno G.

BMC Cancer. 2009 Mar 3;9:74. doi: 10.1186/1471-2407-9-74.

9.

Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype.

Sarrió D, Rodriguez-Pinilla SM, Hardisson D, Cano A, Moreno-Bueno G, Palacios J.

Cancer Res. 2008 Feb 15;68(4):989-97. doi: 10.1158/0008-5472.CAN-07-2017.

10.

Sporadic invasive breast carcinomas with medullary features display a basal-like phenotype: an immunohistochemical and gene amplification study.

Rodríguez-Pinilla SM, Rodríguez-Gil Y, Moreno-Bueno G, Sarrió D, Martín-Guijarro Mdel C, Hernandez L, Palacios J.

Am J Surg Pathol. 2007 Apr;31(4):501-8.

PMID:
17414096
11.

Sox2: a possible driver of the basal-like phenotype in sporadic breast cancer.

Rodriguez-Pinilla SM, Sarrio D, Moreno-Bueno G, Rodriguez-Gil Y, Martinez MA, Hernandez L, Hardisson D, Reis-Filho JS, Palacios J.

Mod Pathol. 2007 Apr;20(4):474-81. Epub 2007 Mar 2.

12.

FGFR1 emerges as a potential therapeutic target for lobular breast carcinomas.

Reis-Filho JS, Simpson PT, Turner NC, Lambros MB, Jones C, Mackay A, Grigoriadis A, Sarrio D, Savage K, Dexter T, Iravani M, Fenwick K, Weber B, Hardisson D, Schmitt FC, Palacios J, Lakhani SR, Ashworth A.

Clin Cancer Res. 2006 Nov 15;12(22):6652-62.

13.

Vimentin and laminin expression is associated with basal-like phenotype in both sporadic and BRCA1-associated breast carcinomas.

Rodríguez-Pinilla SM, Sarrió D, Honrado E, Moreno-Bueno G, Hardisson D, Calero F, Benítez J, Palacios J.

J Clin Pathol. 2007 Sep;60(9):1006-12. Epub 2006 Nov 14.

14.

Genetic profiling of epithelial cells expressing E-cadherin repressors reveals a distinct role for Snail, Slug, and E47 factors in epithelial-mesenchymal transition.

Moreno-Bueno G, Cubillo E, Sarrió D, Peinado H, Rodríguez-Pinilla SM, Villa S, Bolós V, Jordá M, Fabra A, Portillo F, Palacios J, Cano A.

Cancer Res. 2006 Oct 1;66(19):9543-56.

15.

Expression of cadherins and catenins correlates with distinct histologic types of ovarian carcinomas.

Sarrió D, Moreno-Bueno G, Sánchez-Estévez C, Bañón-Rodríguez I, Hernández-Cortés G, Hardisson D, Palacios J.

Hum Pathol. 2006 Aug;37(8):1042-9. Epub 2006 Jun 2.

PMID:
16867867
16.

Delta9-tetrahydrocannabinol inhibits cell cycle progression in human breast cancer cells through Cdc2 regulation.

Caffarel MM, Sarrió D, Palacios J, Guzmán M, Sánchez C.

Cancer Res. 2006 Jul 1;66(13):6615-21.

17.

Abnormal ezrin localization is associated with clinicopathological features in invasive breast carcinomas.

Sarrió D, Rodríguez-Pinilla SM, Dotor A, Calero F, Hardisson D, Palacios J.

Breast Cancer Res Treat. 2006 Jul;98(1):71-9. Epub 2006 Mar 15.

PMID:
16538541
18.

Prognostic significance of basal-like phenotype and fascin expression in node-negative invasive breast carcinomas.

Rodríguez-Pinilla SM, Sarrió D, Honrado E, Hardisson D, Calero F, Benitez J, Palacios J.

Clin Cancer Res. 2006 Mar 1;12(5):1533-9.

19.

High frequency of beta-catenin mutations in borderline endometrioid tumours of the ovary.

Oliva E, Sarrió D, Brachtel EF, Sánchez-Estévez C, Soslow RA, Moreno-Bueno G, Palacios J.

J Pathol. 2006 Apr;208(5):708-13.

PMID:
16429393
20.

Phenotypic characterization of BRCA1 and BRCA2 tumors based in a tissue microarray study with 37 immunohistochemical markers.

Palacios J, Honrado E, Osorio A, Cazorla A, Sarrió D, Barroso A, Rodríguez S, Cigudosa JC, Diez O, Alonso C, Lerma E, Dopazo J, Rivas C, Benítez J.

Breast Cancer Res Treat. 2005 Mar;90(1):5-14.

PMID:
15770521
21.

Cytoplasmic localization of p120ctn and E-cadherin loss characterize lobular breast carcinoma from preinvasive to metastatic lesions.

Sarrió D, Pérez-Mies B, Hardisson D, Moreno-Bueno G, Suárez A, Cano A, Martín-Pérez J, Gamallo C, Palacios J.

Oncogene. 2004 Apr 22;23(19):3272-83.

PMID:
15077190
22.
23.

Immunohistochemical characteristics defined by tissue microarray of hereditary breast cancer not attributable to BRCA1 or BRCA2 mutations: differences from breast carcinomas arising in BRCA1 and BRCA2 mutation carriers.

Palacios J, Honrado E, Osorio A, Cazorla A, Sarrió D, Barroso A, Rodríguez S, Cigudosa JC, Diez O, Alonso C, Lerma E, Sánchez L, Rivas C, Benítez J.

Clin Cancer Res. 2003 Sep 1;9(10 Pt 1):3606-14.

PMID:
14506147
24.

Cyclin D1 gene (CCND1) mutations in endometrial cancer.

Moreno-Bueno G, Rodríguez-Perales S, Sánchez-Estévez C, Hardisson D, Sarrió D, Prat J, Cigudosa JC, Matias-Guiu X, Palacios J.

Oncogene. 2003 Sep 4;22(38):6115-8.

PMID:
12955092
25.

Frequent E-cadherin gene inactivation by loss of heterozygosity in pleomorphic lobular carcinoma of the breast.

Palacios J, Sarrió D, García-Macias MC, Bryant B, Sobel ME, Merino MJ.

Mod Pathol. 2003 Jul;16(7):674-8.

26.

Epigenetic and genetic alterations of APC and CDH1 genes in lobular breast cancer: relationships with abnormal E-cadherin and catenin expression and microsatellite instability.

Sarrió D, Moreno-Bueno G, Hardisson D, Sánchez-Estévez C, Guo M, Herman JG, Gamallo C, Esteller M, Palacios J.

Int J Cancer. 2003 Aug 20;106(2):208-15.

27.

Abnormalities of E- and P-cadherin and catenin (beta-, gamma-catenin, and p120ctn) expression in endometrial cancer and endometrial atypical hyperplasia.

Moreno-Bueno G, Hardisson D, Sarrió D, Sánchez C, Cassia R, Prat J, Herman JG, Esteller M, Matías-Guiu X, Palacios J.

J Pathol. 2003 Apr;199(4):471-8.

PMID:
12635138
28.

Abnormalities of the APC/beta-catenin pathway in endometrial cancer.

Moreno-Bueno G, Hardisson D, Sánchez C, Sarrió D, Cassia R, García-Rostán G, Prat J, Guo M, Herman JG, Matías-Guiu X, Esteller M, Palacios J.

Oncogene. 2002 Nov 14;21(52):7981-90.

29.

Correlation of Snail expression with histological grade and lymph node status in breast carcinomas.

Blanco MJ, Moreno-Bueno G, Sarrio D, Locascio A, Cano A, Palacios J, Nieto MA.

Oncogene. 2002 May 9;21(20):3241-6.

30.

The prognostic significance of P-cadherin in infiltrating ductal breast carcinoma.

Gamallo C, Moreno-Bueno G, Sarrió D, Calero F, Hardisson D, Palacios J.

Mod Pathol. 2001 Jul;14(7):650-4.

31.

Human papillomavirus-16 E6 variants in cervical squamous intraepithelial lesions from HIV-negative and HIV-positive women.

Pérez-Gallego L, Moreno-Bueno G, Sarrió D, Suárez A, Gamallo C, Palacios J.

Am J Clin Pathol. 2001 Jul;116(1):143-8.

PMID:
11447745

Supplemental Content

Loading ...
Support Center